MOUNTAIN VIEW, Calif.,
Feb. 12, 2018 /PRNewswire/ -- To advance the understanding of cell diversity and how that diversity impacts complex cellular functions including interactions with other cells and molecules, growth, and disease states, Takara Bio
USA, Inc., (TBUSA, formerly Clontech Laboratories, Inc.), a wholly owned subsidiary of Takara Bio Inc., is proud to announce the launch of the SMARTer™ ICELL8® cx System. The system will be presented to the scientific community at the Advances in Genome Biology and Technology (AGBT) General Meeting in
Orlando FL, February 12–15, 2018.
Click here for the full article
Monday, February 19, 2018
/Author:
dardeshana/Number of views (81)
/Comments (0)
/ Article rating: No rating